<div id="content" class="col-md-12" style="">
<div data-drupal-messages-fallback="" class="hidden"/><div id="block-medsites-page-title" class="widget block">
<h1><span property="schema:name">Chemotherapy Toxicity</span>
</h1>
</div>
<div id="block-medsites-content" class="widget block">
<article data-history-node-id="1034" role="article" about="/commodorecompendium/chemotherapy-toxicity" typeof="schema:WebPage">
<div>
<div property="schema:text" class="field field--name-body field--type-text-with-summary field--label-hidden field__item"><div class="WordSection1">
<div style="border-bottom:solid windowtext 1.0pt; border-top:double windowtext 1.5pt; border-left:none; border-right:none; padding:1.0pt 0in 1.0pt 0in">
<p style="border:none; padding:0in"><span style="page:WordSection1"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><b><span style="font-size:12.0pt"><span style="font-family:Palatino">Chemotherapy Toxicities - Beau Hilton</span></span></b></span></span></span></span></p>
</div>
<ul>
<li><span style="page:WordSection1"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">The role of Intern/Resident on the Hematology/Oncology services is largely to work with the fellow to monitor and manage adverse effects of chemotherapy</span></span></span></span></span></span></li>
<li><span style="page:WordSection1"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Concerns about specific immune-related adverse event: refer to “Toxicities associated with checkpoint inhibitor immunotherapy,” on UpToDate </span></span></span></span></span></span></li>
<li><span style="page:WordSection1"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="background:white"><span style="font-family:Palatino"><span style="color:#201f1e">Treatment of immune checkpoint inhibitor toxicities: “Management of Immunotherapy-Related Toxicities” in the NCCN Guidelines for Supportive Care section </span></span></span></span></span></span></span></span></li>
</ul>
<p style="margin-left:25px"> </p>
<p><span style="page:WordSection1"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="background:white"><span style="font-family:Palatino"><span style="color:black">Neutropenia:</span></span></span></span></span></span></span></span></p>
<ul>
<li><span style="page:WordSection1"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="background:white"><span style="font-family:Palatino"><span style="color:black">Chemotherapy-associated: usually 5-18 days after treatment</span></span></span></span></span></span></span></span></li>
<li><span style="page:WordSection1"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="background:white"><span style="font-family:Palatino"><span style="color:black">Cancer infiltrate of bone marrow</span></span></span></span></span></span></span></span></li>
<li><span style="page:WordSection1"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="background:white"><span style="font-family:Palatino"><span style="color:black">New occult infection: especially EBV, CMV</span></span></span></span></span></span></span></span></li>
<li><span style="page:WordSection1"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="background:white"><span style="font-family:Palatino"><span style="color:black">Patients can be safely discharged with ANC &gt; 500</span></span></span></span></span></span></span></span></li>
</ul>
<p> </p>
<p><span style="page:WordSection1"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="background:white"><span style="font-family:Palatino"><span style="color:black">Mucositis:</span></span></span></span></span></span></span></span></p>
<ul>
<li><span style="page:WordSection1"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="background:white"><span style="font-family:Palatino"><span style="color:black">Worst in pts receiving concurrent radiation to head and neck, rectum, prostate </span></span></span></span></span></span></span></span></li>
<li><span style="page:WordSection1"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="background:white"><span style="font-family:Palatino"><span style="color:black">Begins shortly after chemo dose, usually peaks on day 7</span></span></span></span></span></span></span></span></li>
<li><span style="page:WordSection1"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="background:white"><span style="font-family:Palatino"><span style="color:black">High risk: bleomycin, cytarabine, anthracyclines, etoposide, 5-FU, methotrexate</span></span></span></span></span></span></span></span></li>
<li><span style="page:WordSection1"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="background:white"><span style="font-family:Palatino"><span style="color:black">Treatment: “Salt and soda” rinses (1 tsp salt, 1 tsp baking sode in 1-quart water, swish and spit 5 times per day), viscous lidocaine, capsaicin candy, Magic Mouthwash</span></span></span></span></span></span></span></span></li>
</ul>
<p> </p>
<p><span style="page:WordSection1"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><b><span style="font-size:12.0pt"><span style="font-family:Palatino">Immune Checkpoint Inhibitor Toxicities:</span></span></b></span></span></span></span></p>
<p><span style="page:WordSection1"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Treatment: low-dose glucocorticoids (prednisone, 0.5 mg/kg) for mild adverse events, high dose glucocorticoids (prednisone, 1-2 mg/kg) for severe adverse events</span></span></span></span></span></span></p>
<table class="Table" style="width:347px; border-collapse:collapse; border:none" width="347">
<tbody>
<tr>
<td style="border-bottom:1px solid black; width:131px; padding:.9px .9px .9px .9px; background-color:black; border-top:1px solid black; border-right:1px solid black; border-left:1px solid black" valign="top">
<p><span style="page:WordSection1"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><b><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:white">Adverse Event Type</span></span></span></b></span></span></span></span></p>
</td>
<td style="border-bottom:1px solid black; width:96px; padding:.9px .9px .9px .9px; background-color:black; border-top:1px solid black; border-right:1px solid black; border-left:none" valign="top">
<p><span style="page:WordSection1"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><b><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:white">Incidence with anti-CTLA-4 (ipilimumab)</span></span></span></b></span></span></span></span></p>
</td>
<td style="border-bottom:1px solid black; width:120px; padding:.9px .9px .9px .9px; background-color:black; border-top:1px solid black; border-right:1px solid black; border-left:none" valign="top">
<p><span style="page:WordSection1"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><b><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:white">Incidence with anti</span></span></span></b><b><span style="font-size:12.0pt"><span style="color:white">‐</span></span></b><b><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:white">PD1/PD</span></span></span></b><b><span style="font-size:12.0pt"><span style="color:white">‐</span></span></b><b><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:white">L1 (nivolumab, pembrolizumab)</span></span></span></b></span></span></span></span></p>
</td>
</tr>
<tr>
<td style="border-bottom:1px solid black; width:131px; padding:.9px .9px .9px .9px; background-color:#d9d9d9; border-top:none; border-right:1px solid black; border-left:1px solid black" valign="top">
<p><span style="page:WordSection1"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black">Skin (pruritus, acne, TEN)</span></span></span></span></span></span></span></p>
</td>
<td style="border-bottom:1px solid black; width:96px; padding:.9px .9px .9px .9px; background-color:#d9d9d9; border-top:none; border-right:1px solid black; border-left:none" valign="top">
<p><span style="page:WordSection1"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black">30%</span></span></span></span></span></span></span></p>
</td>
<td style="border-bottom:1px solid black; width:120px; padding:.9px .9px .9px .9px; background-color:#d9d9d9; border-top:none; border-right:1px solid black; border-left:none" valign="top">
<p><span style="page:WordSection1"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black">30%</span></span></span></span></span></span></span></p>
</td>
</tr>
<tr>
<td style="border-bottom:1px solid black; width:131px; padding:.9px .9px .9px .9px; border-top:none; border-right:1px solid black; border-left:1px solid black" valign="top">
<p><span style="page:WordSection1"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Colitis</span></span></span></span></span></span></p>
</td>
<td style="border-bottom:1px solid black; width:96px; padding:.9px .9px .9px .9px; border-top:none; border-right:1px solid black; border-left:none" valign="top">
<p><span style="page:WordSection1"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">25%</span></span></span></span></span></span></p>
</td>
<td style="border-bottom:1px solid black; width:120px; padding:.9px .9px .9px .9px; border-top:none; border-right:1px solid black; border-left:none" valign="top">
<p><span style="page:WordSection1"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">5%</span></span></span></span></span></span></p>
</td>
</tr>
<tr>
<td style="border-bottom:1px solid black; width:131px; padding:.9px .9px .9px .9px; height:.05in; background-color:#d9d9d9; border-top:none; border-right:1px solid black; border-left:1px solid black" valign="top">
<p><span style="page:WordSection1"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black">Hypothyroidism</span></span></span></span></span></span></span></p>
</td>
<td style="border-bottom:1px solid black; width:96px; padding:.9px .9px .9px .9px; height:.05in; background-color:#d9d9d9; border-top:none; border-right:1px solid black; border-left:none" valign="top">
<p><span style="page:WordSection1"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black">20%</span></span></span></span></span></span></span></p>
</td>
<td style="border-bottom:1px solid black; width:120px; padding:.9px .9px .9px .9px; height:.05in; background-color:#d9d9d9; border-top:none; border-right:1px solid black; border-left:none" valign="top">
<p><span style="page:WordSection1"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black">20%</span></span></span></span></span></span></span></p>
</td>
</tr>
<tr>
<td style="border-bottom:1px solid black; width:131px; padding:.9px .9px .9px .9px; height:.05in; border-top:none; border-right:1px solid black; border-left:1px solid black" valign="top">
<p><span style="page:WordSection1"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Hepatitis </span></span></span></span></span></span></p>
</td>
<td style="border-bottom:1px solid black; width:96px; padding:.9px .9px .9px .9px; height:.05in; border-top:none; border-right:1px solid black; border-left:none" valign="top">
<p><span style="page:WordSection1"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">10%</span></span></span></span></span></span></p>
</td>
<td style="border-bottom:1px solid black; width:120px; padding:.9px .9px .9px .9px; height:.05in; border-top:none; border-right:1px solid black; border-left:none" valign="top">
<p><span style="page:WordSection1"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">1%</span></span></span></span></span></span></p>
</td>
</tr>
<tr>
<td style="border-bottom:1px solid black; width:131px; padding:.9px .9px .9px .9px; height:.05in; background-color:#d9d9d9; border-top:none; border-right:1px solid black; border-left:1px solid black" valign="top">
<p><span style="page:WordSection1"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black">Hypophysitis</span></span></span></span></span></span></span></p>
</td>
<td style="border-bottom:1px solid black; width:96px; padding:.9px .9px .9px .9px; height:.05in; background-color:#d9d9d9; border-top:none; border-right:1px solid black; border-left:none" valign="top">
<p><span style="page:WordSection1"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black">10%</span></span></span></span></span></span></span></p>
</td>
<td style="border-bottom:1px solid black; width:120px; padding:.9px .9px .9px .9px; height:.05in; background-color:#d9d9d9; border-top:none; border-right:1px solid black; border-left:none" valign="top">
<p><span style="page:WordSection1"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black">rare</span></span></span></span></span></span></span></p>
</td>
</tr>
<tr>
<td style="border-bottom:1px solid black; width:131px; padding:.9px .9px .9px .9px; height:.05in; border-top:none; border-right:1px solid black; border-left:1px solid black" valign="top">
<p><span style="page:WordSection1"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Pneumonitis </span></span></span></span></span></span></p>
</td>
<td style="border-bottom:1px solid black; width:96px; padding:.9px .9px .9px .9px; height:.05in; border-top:none; border-right:1px solid black; border-left:none" valign="top">
<p><span style="page:WordSection1"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">2-5%</span></span></span></span></span></span></p>
</td>
<td style="border-bottom:1px solid black; width:120px; padding:.9px .9px .9px .9px; height:.05in; border-top:none; border-right:1px solid black; border-left:none" valign="top">
<p><span style="page:WordSection1"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">2-5%</span></span></span></span></span></span></p>
</td>
</tr>
<tr>
<td style="border-bottom:1px solid black; width:131px; padding:.9px .9px .9px .9px; height:.05in; background-color:#d9d9d9; border-top:none; border-right:1px solid black; border-left:1px solid black" valign="top">
<p><span style="page:WordSection1"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black">Myocarditis (fatality&gt;25%)</span></span></span></span></span></span></span></p>
</td>
<td style="border-bottom:1px solid black; width:96px; padding:.9px .9px .9px .9px; height:.05in; background-color:#d9d9d9; border-top:none; border-right:1px solid black; border-left:none" valign="top">
<p><span style="page:WordSection1"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black">&lt;1%</span></span></span></span></span></span></span></p>
</td>
<td style="border-bottom:1px solid black; width:120px; padding:.9px .9px .9px .9px; height:.05in; background-color:#d9d9d9; border-top:none; border-right:1px solid black; border-left:none" valign="top">
<p><span style="page:WordSection1"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black">&lt;1%</span></span></span></span></span></span></span></p>
</td>
</tr>
<tr>
<td style="border-bottom:1px solid black; width:131px; padding:.9px .9px .9px .9px; border-top:none; border-right:1px solid black; border-left:1px solid black" valign="top">
<p><span style="page:WordSection1"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Neurotoxicity (GBS, myasthenia gravis, encephalitis)</span></span></span></span></span></span></p>
</td>
<td style="border-bottom:1px solid black; width:96px; padding:.9px .9px .9px .9px; border-top:none; border-right:1px solid black; border-left:none" valign="top">
<p><span style="page:WordSection1"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">&lt;1%</span></span></span></span></span></span></p>
</td>
<td style="border-bottom:1px solid black; width:120px; padding:.9px .9px .9px .9px; border-top:none; border-right:1px solid black; border-left:none" valign="top">
<p><span style="page:WordSection1"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">&lt;1%</span></span></span></span></span></span></p>
</td>
</tr>
</tbody>
</table>
</div>
<p> </p>
<p><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><b><span style="font-size:12.0pt"><span style="font-family:Palatino">Chemotherapeutic Agent </span></span></b><b><span style="font-size:12.0pt"><span style="font-family:Palatino">Toxicities</span></span></b></span></span></span></p>
<table class="Table" style="width:100.0%; border-collapse:collapse; border:none" width="100%">
<thead>
<tr>
<td style="border-bottom:1px solid black; width:28%; padding:.9px .9px .9px .9px; background-color:black; border-top:1px solid black; border-right:1px solid black; border-left:1px solid black" valign="top">
<p style="margin-bottom:11px"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><b><span style="font-size:12.0pt"><span style="font-family:Palatino">Organ System</span></span></b></span></span></span></p>
</td>
<td style="border-bottom:1px solid black; width:35%; padding:.9px .9px .9px .9px; background-color:black; border-top:1px solid black; border-right:1px solid black; border-left:none" valign="top">
<p style="margin-bottom:11px"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><b><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:white">Agent</span></span></span></b></span></span></span></p>
</td>
<td style="border-bottom:1px solid black; width:35%; padding:.9px .9px .9px .9px; background-color:black; border-top:1px solid black; border-right:1px solid black; border-left:none" valign="top">
<p style="margin-bottom:11px"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><b><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:white"> Side Effect</span></span></span></b></span></span></span></p>
</td>
</tr>
</thead>
<tbody>
<tr>
<td rowspan="3" style="border-bottom:1px solid black; width:28%; padding:.9px .9px .9px .9px; background-color:#d9d9d9; border-top:none; border-right:1px solid black; border-left:1px solid black">
<p align="center" style="text-align:center; margin-bottom:11px"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black">Alkylating Agents</span></span></span></span></span></span></p>
</td>
<td style="border-bottom:1px solid black; width:35%; padding:.9px .9px .9px .9px; background-color:#d9d9d9; border-top:none; border-right:1px solid black; border-left:none" valign="top">
<p style="margin-bottom:11px"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black">Busulfan</span></span></span></span></span></span></p>
</td>
<td style="border-bottom:1px solid black; width:35%; padding:.9px .9px .9px .9px; background-color:#d9d9d9; border-top:none; border-right:1px solid black; border-left:none" valign="top">
<p style="margin-bottom:11px"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black">Pulmonary fibrosis or diffuse alveolar hemorrhage (8%)</span></span></span></span></span></span></p>
</td>
</tr>
<tr>
<td style="border-bottom:1px solid black; width:35%; padding:.9px .9px .9px .9px; background-color:#d9d9d9; border-top:none; border-right:1px solid black; border-left:none" valign="top">
<p style="margin-bottom:11px"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black">Cyclophosphamide </span></span></span></span></span></span></p>
</td>
<td style="border-bottom:1px solid black; width:35%; padding:.9px .9px .9px .9px; background-color:#d9d9d9; border-top:none; border-right:1px solid black; border-left:none" valign="top">
<p style="margin-bottom:11px"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black">Myopericarditis. Hemorrhagic cystitis (prevention: hydration; monitoring: daily UA, Tx: Mesna</span></span></span></span></span></span></p>
</td>
</tr>
<tr>
<td style="border-bottom:1px solid black; width:35%; padding:.9px .9px .9px .9px; background-color:#d9d9d9; border-top:none; border-right:1px solid black; border-left:none" valign="top">
<p style="margin-bottom:11px"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black">Ifosfamide</span></span></span></span></span></span></p>
</td>
<td style="border-bottom:1px solid black; width:35%; padding:.9px .9px .9px .9px; background-color:#d9d9d9; border-top:none; border-right:1px solid black; border-left:none" valign="top">
<p style="margin-bottom:11px"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black">Encephalopathy (tx: methylene blue)</span></span></span></span></span></span></p>
</td>
</tr>
<tr>
<td rowspan="5" style="border-bottom:1px solid black; width:28%; padding:.9px .9px .9px .9px; height:20px; border-top:none; border-right:1px solid black; border-left:1px solid black">
<p align="center" style="text-align:center; margin-bottom:11px"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Antimetabolites</span></span></span></span></span></p>
</td>
<td style="border-bottom:1px solid black; width:35%; padding:.9px .9px .9px .9px; height:20px; border-top:none; border-right:1px solid black; border-left:none" valign="top">
<p style="margin-bottom:11px"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">5- Fluorouracil (5-FU)/ Capecitabine (metabolized to FU)</span></span></span></span></span></p>
</td>
<td style="border-bottom:1px solid black; width:35%; padding:.9px .9px .9px .9px; height:20px; border-top:none; border-right:1px solid black; border-left:none" valign="top">
<p style="margin-bottom:11px"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Coronary vasospasm (ppx: CCB); palmar-plantar erythrodysesthesia</span></span></span></span></span></p>
</td>
</tr>
<tr>
<td style="border-bottom:1px solid black; width:35%; padding:.9px .9px .9px .9px; border-top:none; border-right:1px solid black; border-left:none" valign="top">
<p style="margin-bottom:11px"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Cladribine, pentostatin</span></span></span></span></span></p>
</td>
<td style="border-bottom:1px solid black; width:35%; padding:.9px .9px .9px .9px; border-top:none; border-right:1px solid black; border-left:none" valign="top">
<p style="margin-bottom:11px"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Dose reduced for CrCl</span></span></span></span></span></p>
</td>
</tr>
<tr>
<td style="border-bottom:1px solid black; width:35%; padding:.9px .9px .9px .9px; height:12px; border-top:none; border-right:1px solid black; border-left:none" valign="top">
<p style="margin-bottom:11px"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Cytarabine (Ara-C)</span></span></span></span></span></p>
</td>
<td style="border-bottom:1px solid black; width:35%; padding:.9px .9px .9px .9px; height:12px; border-top:none; border-right:1px solid black; border-left:none" valign="top">
<p style="margin-bottom:11px"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Irreversible cerebellar ataxia (if high dose, neuro checks required). Conjunctivitis (prevent with prophylactic steroid eye drops)</span></span></span></span></span></p>
</td>
</tr>
<tr>
<td style="border-bottom:1px solid black; width:35%; padding:.9px .9px .9px .9px; height:20px; border-top:none; border-right:1px solid black; border-left:none" valign="top">
<p style="margin-bottom:11px"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Gemcitabine</span></span></span></span></span></p>
</td>
<td style="border-bottom:1px solid black; width:35%; padding:.9px .9px .9px .9px; height:20px; border-top:none; border-right:1px solid black; border-left:none" valign="top">
<p style="margin-bottom:11px"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Transient transaminitis. Decrease dose only if hyperbilirubinemia.</span></span></span></span></span></p>
</td>
</tr>
<tr>
<td style="border-bottom:1px solid black; width:35%; padding:.9px .9px .9px .9px; height:20px; border-top:none; border-right:1px solid black; border-left:none" valign="top">
<p style="margin-bottom:11px"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Methotrexate</span></span></span></span></span></p>
</td>
<td style="border-bottom:1px solid black; width:35%; padding:.9px .9px .9px .9px; height:20px; border-top:none; border-right:1px solid black; border-left:none" valign="top">
<p style="margin-bottom:11px"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Hepatotoxicity, renal failure, high dose requires leucovorin</span></span></span></span></span></p>
</td>
</tr>
<tr>
<td rowspan="2" style="border-bottom:1px solid black; width:28%; padding:.9px .9px .9px .9px; background-color:#d9d9d9; border-top:none; border-right:1px solid black; border-left:1px solid black">
<p align="center" style="text-align:center; margin-bottom:11px"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black">Antitumor antibiotics</span></span></span></span></span></span></p>
</td>
<td style="border-bottom:1px solid black; width:35%; padding:.9px .9px .9px .9px; background-color:#d9d9d9; border-top:none; border-right:1px solid black; border-left:none" valign="top">
<p style="margin-bottom:11px"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black">Anthracyclines (doxorubicin, duanorubicin, idarubicin)</span></span></span></span></span></span></p>
</td>
<td style="border-bottom:1px solid black; width:35%; padding:.9px .9px .9px .9px; background-color:#d9d9d9; border-top:none; border-right:1px solid black; border-left:none" valign="top">
<p style="margin-bottom:11px"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black">HFrEF (need TTE prior). Most notable with doxorubicin.</span></span></span></span></span></span></p>
</td>
</tr>
<tr>
<td style="border-bottom:1px solid black; width:35%; padding:.9px .9px .9px .9px; height:2px; background-color:#d9d9d9; border-top:none; border-right:1px solid black; border-left:none" valign="top">
<p style="margin-bottom:11px"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black">Bleomycin</span></span></span></span></span></span></p>
</td>
<td style="border-bottom:1px solid black; width:35%; padding:.9px .9px .9px .9px; height:2px; background-color:#d9d9d9; border-top:none; border-right:1px solid black; border-left:none" valign="top">
<p style="margin-bottom:11px"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black">Pulmonary fibrosis (10%). Potentiated with G-CSF</span></span></span></span></span></span></p>
</td>
</tr>
<tr>
<td rowspan="3" style="border-bottom:1px solid black; width:28%; padding:.9px .9px .9px .9px; border-top:none; border-right:1px solid black; border-left:1px solid black">
<p align="center" style="text-align:center; margin-bottom:11px"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Monoclonal Antibodies</span></span></span></span></span></p>
</td>
<td style="border-bottom:1px solid black; width:35%; padding:.9px .9px .9px .9px; border-top:none; border-right:1px solid black; border-left:none" valign="top">
<p style="margin-bottom:11px"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Alemtuzumab</span></span></span></span></span></p>
</td>
<td style="border-bottom:1px solid black; width:35%; padding:.9px .9px .9px .9px; border-top:none; border-right:1px solid black; border-left:none" valign="top">
<p style="margin-bottom:11px"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Severe and prolonged cytopenias</span></span></span></span></span></p>
</td>
</tr>
<tr>
<td style="border-bottom:1px solid black; width:35%; padding:.9px .9px .9px .9px; border-top:none; border-right:1px solid black; border-left:none" valign="top">
<p style="margin-bottom:11px"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Bevacizumab</span></span></span></span></span></p>
</td>
<td style="border-bottom:1px solid black; width:35%; padding:.9px .9px .9px .9px; border-top:none; border-right:1px solid black; border-left:none" valign="top">
<p style="margin-bottom:11px"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">HFrEF, HTN, hyperglycemia, hypomag, DVT, pulm hemorrhage</span></span></span></span></span></p>
</td>
</tr>
<tr>
<td style="border-bottom:1px solid black; width:35%; padding:.9px .9px .9px .9px; border-top:none; border-right:1px solid black; border-left:none" valign="top">
<p style="margin-bottom:11px"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Rituximab</span></span></span></span></span></p>
</td>
<td style="border-bottom:1px solid black; width:35%; padding:.9px .9px .9px .9px; border-top:none; border-right:1px solid black; border-left:none" valign="top">
<p style="margin-bottom:11px"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Hypophos, hepatotoxicity, HBV reactivation (screen all patients), peripheral neuropathy </span></span></span></span></span></p>
</td>
</tr>
<tr>
<td style="border-bottom:1px solid black; width:28%; padding:.9px .9px .9px .9px; background-color:#d9d9d9; border-top:none; border-right:1px solid black; border-left:1px solid black">
<p align="center" style="text-align:center; margin-bottom:11px"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black">Platinum Agents</span></span></span></span></span></span></p>
</td>
<td style="border-bottom:1px solid black; width:35%; padding:.9px .9px .9px .9px; background-color:#d9d9d9; border-top:none; border-right:1px solid black; border-left:none" valign="top">
<p style="margin-bottom:11px"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black">Cisplatin, oxaliplatin, carboplatin</span></span></span></span></span></span></p>
</td>
<td style="border-bottom:1px solid black; width:35%; padding:.9px .9px .9px .9px; background-color:#d9d9d9; border-top:none; border-right:1px solid black; border-left:none" valign="top">
<p style="margin-bottom:11px"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black">Nephrotoxicity, worst with cisplatin. Rental tubular acidosis. Neurotoxicity- &gt;85% oxaliplatin (parasthesias, cold sensitivity, cramps), neuropathy, ototoxicity</span></span></span></span></span></span></p>
</td>
</tr>
<tr>
<td style="border-bottom:1px solid black; width:28%; padding:.9px .9px .9px .9px; border-top:none; border-right:1px solid black; border-left:1px solid black">
<p align="center" style="text-align:center; margin-bottom:11px"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Taxanes</span></span></span></span></span></p>
</td>
<td style="border-bottom:1px solid black; width:35%; padding:.9px .9px .9px .9px; border-top:none; border-right:1px solid black; border-left:none" valign="top">
<p style="margin-bottom:11px"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Docetaxel, paclitaxel </span></span></span></span></span></p>
</td>
<td style="border-bottom:1px solid black; width:35%; padding:.9px .9px .9px .9px; border-top:none; border-right:1px solid black; border-left:none" valign="top">
<p style="margin-bottom:11px"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino">Hypersensivitivy reaction. Often require premedication with steroids and H1/H2 blockers.</span></span></span></span></span></p>
</td>
</tr>
<tr>
<td style="border-bottom:1px solid black; width:28%; padding:.9px .9px .9px .9px; background-color:#d9d9d9; border-top:none; border-right:1px solid black; border-left:1px solid black">
<p align="center" style="text-align:center; margin-bottom:11px"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black">Topoisomerase Inhibitors</span></span></span></span></span></span></p>
</td>
<td style="border-bottom:1px solid black; width:35%; padding:.9px .9px .9px .9px; background-color:#d9d9d9; border-top:none; border-right:1px solid black; border-left:none" valign="top">
<p style="margin-bottom:11px"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black">Irinotecan, topotecan, etoposide</span></span></span></span></span></span></p>
</td>
<td style="border-bottom:1px solid black; width:35%; padding:.9px .9px .9px .9px; background-color:#d9d9d9; border-top:none; border-right:1px solid black; border-left:none" valign="top">
<p style="margin-bottom:11px"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black">Irinotecan- acute diarrhea can be treated with atropine</span></span></span></span></span></span></p>
</td>
</tr>
<tr>
<td style="border-bottom:1px solid black; width:28%; padding:.9px .9px .9px .9px; height:12px; background-color:white; border-top:none; border-right:1px solid black; border-left:1px solid black">
<p align="center" style="text-align:center; margin-bottom:11px"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black">Tyrosine Kinase Inhibitors</span></span></span></span></span></span></p>
</td>
<td style="border-bottom:1px solid black; width:35%; padding:.9px .9px .9px .9px; height:12px; background-color:white; border-top:none; border-right:1px solid black; border-left:none" valign="top">
<p style="margin-bottom:11px"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black">Imatinib, Dasatinib, Nilotinib, Bosutinib</span></span></span></span></span></span></p>
</td>
<td style="border-bottom:1px solid black; width:35%; padding:.9px .9px .9px .9px; height:12px; background-color:white; border-top:none; border-right:1px solid black; border-left:none" valign="top">
<p style="margin-bottom:11px"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black">Qtc prolongation, pulmonary effusion, hepatotoxicity</span></span></span></span></span></span></p>
</td>
</tr>
<tr>
<td style="border-bottom:1px solid black; width:28%; padding:.9px .9px .9px .9px; background-color:#d9d9d9; border-top:none; border-right:1px solid black; border-left:1px solid black">
<p align="center" style="text-align:center; margin-bottom:11px"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black">Vinca alkaloid</span></span></span></span></span></span></p>
</td>
<td style="border-bottom:1px solid black; width:35%; padding:.9px .9px .9px .9px; background-color:#d9d9d9; border-top:none; border-right:1px solid black; border-left:none" valign="top">
<p style="margin-bottom:11px"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black">Vincristine</span></span></span></span></span></span></p>
</td>
<td style="border-bottom:1px solid black; width:35%; padding:.9px .9px .9px .9px; background-color:#d9d9d9; border-top:none; border-right:1px solid black; border-left:none" valign="top">
<p style="margin-bottom:11px"><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:Calibri,sans-serif"><span style="font-size:12.0pt"><span style="font-family:Palatino"><span style="color:black">Peripheral neuropathy and ototoxicity (vestibular system lost first)</span></span></span></span></span></span></p>
</td>
</tr>
</tbody>
</table>
</div>
</div>
</article>
</div>
</div>